Clinical Trial Update: Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy

View source ↗

Summary

Observational study assessing adverse events in adult women treated with Ubrelvy (ubrogepant) or Qulipta (atogepant) during pregnancy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Qulipta (atogepant)
• Ubrelvy (ubrogepant)

Snippet

Sponsor: AbbVie | Conditions: Migraine | Status: RECRUITING